SHUKRAPHAR vs WELSPUNLIV: Stock Comparison
Head-to-head financial and trading comparison between Shukra Pharmaceuticals Limited (SHUKRAPHAR) and Welspun Living Limited (WELSPUNLIV) in the Cross-Sector Peers sector.
SHUKRAPHAR
NSE: SHUKRAPHARWELSPUNLIV
NSE: WELSPUNLIVKey Metrics Comparison Table
| Metric | SHUKRAPHAR | WELSPUNLIV | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹66.94 | ₹223.75 | — |
| 1-Year Price Return | +61.61% | +76.31% | WELSPUNLIV (14.70% higher) |
| 52-Week High | ₹72.58 | ₹239.17 | — |
| 52-Week Low | ₹41.42 | ₹126.91 | — |
| 30-Day Annualized Volatility | 64.68% | 35.87% | WELSPUNLIV (Steadier) |
| 30-Day Average Daily Volume | 6,592,919 | 4,900,919 | SHUKRAPHAR (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SHUKRAPHAR and WELSPUNLIV, which stock gave better returns over the last year?
WELSPUNLIV has outperformed SHUKRAPHAR over the past 12 months with a gain of 76.31% compared to 61.61%.
Which stock is less volatile: SHUKRAPHAR or WELSPUNLIV?
WELSPUNLIV demonstrated lower price volatility (35.87% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SHUKRAPHAR vs WELSPUNLIV?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SHUKRAPHAR and WELSPUNLIV direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.